AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glitaray M Plus 4mg/850mg Tablet

Prescription Icon
Prescription Required

Marketer

Lloyd Healthcare Pvt Ltd

Salt Composition

Glimepiride (4mg) + Metformin (850mg)

Overview Glitaray M Plus 4mg/850mg Tablet

Diabex Duo 4mg/850mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabex Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of kidney complications, vision loss, neuropathy, and limb amputation. This medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as advised by your doctor. Lifestyle choices significantly influence diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with its symptoms (sweating, dizziness, headache, tremors) and appropriate management. Maintain regular mealtimes and carry a quick-acting glucose source (e.g., sugary sweets, fruit juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their doctor before starting treatment. Consult your physician before use during pregnancy or breastfeeding. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.

Uses of Glitaray M Plus 4mg/850mg Tablet

Managing Type 2 Diabetes

Major Benefits of Glitaray M Plus 4mg/850mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glitaray M Plus 4mg/850mg Tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.

Common Side effects of Glitaray M Plus 4mg/850mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glitaray M Plus 4mg/850mg Tablet:

Consume Glitaray M Plus 4mg/850mg tablets precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablets whole; avoid chewing, crushing, or fracturing them. Administration should coincide with mealtimes.

How Glitaray M Plus 4mg/850mg Tablet works:

Each Glitaray M Plus 4mg/850mg tablet combines glimepiride (a sulfonylurea) and metformin (a biguanide), two agents that manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose. Metformin lowers liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glitaray M Plus 4mg/850mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glitaray M Plus 4mg/850mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glitaray M Plus 4mg/850mg Tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Exercise caution when administering Glitaray M Plus 4mg/850mg tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. The use of Glitaray M Plus 4mg/850mg tablets is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glitaray M Plus 4mg/850mg Tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation should be at a reduced dose; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glitaray M Plus 4mg/850mg Tablet :

Should you forget a Glitaray M Plus 4mg/850mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glitaray M Plus 4mg/850mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glitaray M Plus 4mg/850mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Glitaray M Plus 4mg/850mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Glitaray M Plus 4mg/850mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glitaray M Plus 4mg/850mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glitaray M Plus 4mg/850mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplementation with external vitamin B12 sources is recommended by some researchers.
Glitaray M Plus 4mg/850mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glitaray M Plus 4mg/850mg tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glitaray M Plus 4mg/850mg...
123
MRP 142
13% off